Haoxi Health Technology Limited (HAO) Revenue History
Annual and quarterly revenue from 2021 to present
HAO Revenue Over Time (2021–2025)
HAO Revenue Growth History
3 of 4 years with positive growth- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- +25.8%
- FY2023 revenue growth
- +74.7%
- FY2024 revenue growth
- +71.9%
- FY2025 revenue growth
- -32.4%
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $33.8M | +41.2% |
| Q4 2025 | $8.8M | -64.6% |
| Q2 2025 | $24.0M | +1.9% |
| Q4 2024 | $25.0M | +31.2% |
| Q2 2024 | $23.5M | +156.5% |
| Q4 2023 | $19.1M | +136.0% |
| Q2 2023 | $9.2M | +13.4% |
| Q4 2022 | $8.1M | +25.8% |
HAO Revenue Analysis (2021–2025)
Current Revenue & Growth
As of June 23, 2026, Haoxi Health Technology Limited (HAO) generated trailing twelve-month (TTM) revenue of $91.6 million, reflecting explosive growth of +41.2% year-over-year. The most recent quarter (Q2 2026) recorded $33.8 million in revenue, up 282.3% sequentially.
Historical Growth Trajectory
HAO's historical revenue data shows a 3-year CAGR of +26.6%. Haoxi Health Technology Limited's highest annual revenue of $48.5 million was recorded in 2024.
Peer Comparison
Compared to Communication Services sector peers — including BTBT, CLPS (+0.9% YoY), and AIXI (-22.9% YoY) — HAO has outperformed the peer group in revenue growth. Compare HAO vs BTBT →
HAO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HAOCurrent | $92M | +41.2% | - | -6.1% | |
 BTBT | $114M | - | - | -49.8% | |
 CLPS | $164M | +0.9% | +13.0% | -4.0% | |
 AIXI | $12M | -22.9% | -2.3% | -783.6% | |
 RCON | $66M | -26.8% | +0.4% | -86.5% | |
 CNET | $5M | -75.3% | -34.5% | -42.3% |
HAO Historical Revenue Data (2021–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $32.8M | -32.4% | $928K | 2.8% | $-1,999,903 | -6.1% |
| 2024 | $48.5M | +71.9% | $2.8M | 5.7% | $1.7M | 3.5% |
| 2023 | $28.2M | +74.7% | $2.1M | 7.3% | $1.2M | 4.2% |
| 2022 | $16.2M | +25.8% | $649K | 4.0% | $269K | 1.7% |
| 2021 | $12.8M | - | $606K | 4.7% | $331K | 2.6% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HAO — Frequently Asked Questions
Quick answers to the most common questions about buying HAO stock.
Is HAO's revenue growth accelerating or slowing?
HAO revenue growth is accelerating. TTM revenue reached $92M, up +41.2% year-over-year — ahead of the 5-year CAGR of N/A. This indicates the business is expanding faster than its historical baseline.
What is HAO's revenue history from 2021 to 2026?
Haoxi Health Technology Limited (HAO) revenue history spans 2021 to 2026. TTM revenue as of 2026 is $92M, growing at +41.2% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is HAO's long-term revenue growth rate (CAGR)?
Haoxi Health Technology Limited's 5-year revenue CAGR of N/A reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +41.2% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for HAO.
Why does HAO's quarterly revenue fluctuate?
HAO quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Haoxi Health Technology Limited's revenue data from 2021 to 2026 shows full historical quarterly detail on this page.
How is HAO's revenue distributed by segment?
HAO reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does HAO's revenue compare to industry peers?
Haoxi Health Technology Limited (HAO) with TTM revenue of $92M and +41.2% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.